NP / PA
Dalehite-Stringfellow, Julie
Dalehite-Stringfellow, Julie was paid $173K by Medicaid between Jan 2018 and Jun 2022, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 63% of everything it billed.
33Billing provider infoDALEHITE-STRINGFELLOW, JULIE
MILLINGTON, TN 38053
MILLINGTON, TN 38053
33aNPI1841295854assigned 06/16/2005
33bProvider typeFamily Nurse Practitioner
28Total paid$173K
24GClaims16,654
24DCodes billed23
24AFirst – last monthJan 2018 – Jun 2022
Compared with peers
Next to other Family Nurse Practitioner providers in Tennessee
Rank by total paid#94 of 687
Median peer was paid$15K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,254 | $48K | |
| 2019 | 4,669 | $44K | |
| 2020 | 3,851 | $46K | |
| 2021 | 3,762 | $35K | |
| 2022 | 118 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 63% | 4,028 | 3,106 | $110K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 1,795 | 1,363 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9.9% | 2,692 | 1,379 | $17K |
| 80305 | 1.3% | 1,288 | 1,150 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 242 | 197 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 76 | 55 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,083 | 1,764 | $1K |
| 81002 | <1% | 1,507 | 1,227 | $1K | |
| 96130 | <1% | 24 | 18 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 14 | 14 | $879.48 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 45 | 34 | $792.92 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 186 | 131 | $742.26 |
11 more codes
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 523 | $635.81 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,120 | $373.01 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 691 | $239.21 |
| 90686 | <1% | 21 | $171.44 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 148 | $102.92 |
| 90661 | <1% | 13 | $93.84 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 18 | $91.84 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 19 | $79.20 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 40 | $5.28 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 56 | $1.60 |
| 97802 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.